<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Hyperglycemia and Incidence of Ischemic and Hemorrhagic Stroke-Comparison Between Fasting and 2-Hour Glucose Criteria</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Marjukka</forename><surname>Hyva</surname></persName>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Jaakko</forename><surname>Tuomilehto</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Markku</forename><surname>Ma ¨ho ¨nen</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">;</forename><surname>Coen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">D</forename><forename type="middle">A</forename><surname>Stehouwer</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">;</forename><surname>Kalevi</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, PhD; Bjo</roleName><forename type="first">Pyo</forename><surname>¨ra ¨la ¨</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">¨rn</forename><surname>Zethelius</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Qing</forename><surname>Qiao</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>MSc</roleName><forename type="first">Marjukka</forename><surname>Hyva ¨rinen</surname></persName>
							<email>marjukka.hyvarinen@helsinki.fi</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Chronic Disease Prevention (J.T</orgName>
								<orgName type="laboratory">the Diabetes Prevention Unit</orgName>
								<orgName type="institution">University of Helsinki</orgName>
								<address>
									<region>M.M., Q.Q.)</region>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Medicine (C.D.A.S.)</orgName>
								<orgName type="institution">National Institute for Health and Welfare</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine (K.P.)</orgName>
								<orgName type="institution">Maastricht University Medical Centre</orgName>
								<address>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">University of Kuopio</orgName>
								<address>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Public Health/Geriatrics (B.Z.)</orgName>
								<orgName type="institution">Uppsala University Hospital</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Department of Public Health</orgName>
								<orgName type="institution">University of Helsinki</orgName>
								<address>
									<addrLine>PL 41, Mannerheimintie 172</addrLine>
									<postCode>FIN-00014</postCode>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Hyperglycemia and Incidence of Ischemic and Hemorrhagic Stroke-Comparison Between Fasting and 2-Hour Glucose Criteria</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">E171AEE997EFAA0D2FE17A00AD76D025</idno>
					<idno type="DOI">10.1161/STROKEAHA.108.539650</idno>
					<note type="submission">Received October 8, 2008; final revision received November 10, 2008; accepted November 14, 2008.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.1" ident="GROBID" when="2022-07-19T22:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Background and Purpose-We examined the impact of hyperglycemia on ischemic and hemorrhagic stroke incidence comparing criteria based on fasting plasma glucose (FPG) and 2-hour plasma glucose (2-hour PG). Methods-Data from 9 European cohorts comprising 18 360 individuals between 25 to 90 years of age were collaboratively analyzed. The maximum length of follow-up varied between 4.9 to 36.8 years. Hazards ratios (95% confidence intervals) for stroke incidence were estimated using Cox-proportional hazards model adjusting for known risk factors. Results-In individuals without a prior history of diabetes, the multivariate-adjusted hazards ratio for ischemic stroke corresponding to 1 SD increase in FPG was 1.12 (1.02 to 1.22) and in 2-hour PG 1.14 (1.05 to 1.24). Adding 2-hour PG to the model with FPG significantly improved the prediction of the model for the incidence of ischemic stroke ( 2 ϭ4.72, Pϭ0.03), whereas FPG did not improve the 2-hour PG model prediction ( 2 ϭ0.25, Pϭ0.62). A significantly increased hazard ratio was also observed for previously diagnosed diabetes (2.26 [1.51 to 3.38]) and for screen-detected diabetes defined by FPG (1.48 [1.08 to 2.02]) and 2-hour PG (1.60 [1.18 to 2.16]). None of the criteria predicted hemorrhagic stroke. Conclusions-Diabetes defined by either of the criteria predicted the future risk of ischemic stroke but not the hemorrhagic stroke. The prediction is stronger for elevated 2-hour PG than for FPG levels. (Stroke. 2009;40:1633-1637.) Key Words: fasting plasma glucose Ⅲ 2-h plasma glucose Ⅲ ischemic stroke Ⅲ hemorrhagic stroke Ⅲ incidence D iabetes is an independent well-known risk factor for</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>stroke. <ref type="bibr" target="#b0">1</ref> Several studies have addressed the issue of diabetes and different subtypes of stroke. 2,3,4 Some 2,5 but not all <ref type="bibr" target="#b5">6</ref> studies have found an increased risk of ischemic stroke but no association <ref type="bibr" target="#b2">3</ref> or a decreased risk of hemorrhagic stroke in individuals with diabetes. <ref type="bibr" target="#b3">4</ref> The pathophysiology between ischemic stroke and hemorrhagic stroke differs. <ref type="bibr" target="#b6">7</ref> Atherosclerosis is a known risk factor for stroke, <ref type="bibr" target="#b7">8</ref> and it is often advanced in individuals with hyperglycemia <ref type="bibr" target="#b8">9</ref> or diabetes. <ref type="bibr" target="#b9">10</ref> Atherosclerosis has been found to be more strongly associated with postchallenge glucose levels than fasting glucose levels. <ref type="bibr" target="#b10">11</ref> Yet, studies have also indicated that elevated serum fasting <ref type="bibr" target="#b11">12</ref> and nonfasting <ref type="bibr" target="#b4">5</ref> glucose levels increase the risk of ischemic stroke. The association between diabetes and hemorrhagic stroke is controversial. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b12">13</ref> However, diabetes often coexists with hypertension, <ref type="bibr" target="#b13">14</ref> which has been reported to have an association with cerebral hemorrhage. <ref type="bibr" target="#b14">15</ref> The aim of the present study is to investigate the relationship between the incidence of ischemic and hemorrhagic stroke and hyperglycemia and to compare the differences between fasting and 2-hour plasma glucose criteria.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Population</head><p>This is a subdata analysis of the DECODE study including 9 cohorts from Finland and Sweden and consisting of 18 360 participants with 9985 men and 8375 women. Individuals participating at the baseline survey were followed up until 2006 and 2004 for the Finnish and the Swedish cohorts, respectively. The data on stroke mortality and morbidity were collected from National Causes of Death Register and the National Hospital Discharge Registry and ascertained by using a computerized record linkage of individual ID numbers of each of the individuals participating in the study. The age range of the study population varied from 25 to 90 years. The maximum length of follow-up varied between 4.9 to 36.8 years in between the different cohorts with a median length of follow-up of 12.9 years. Individuals with a prior history of diabetes were classified as previously diagnosed diabetes. Further classification was made on the basis of fasting plasma glucose (FPG) and 2-hour plasma (2-hour PG) glucose criteria for individuals who had not previously been diagnosed as diabetic according to the WHO 2006 criteria. <ref type="bibr" target="#b15">16</ref> For FPG levels Ն7.0 mmol/L and 2-hour PG levels Ն11.1 mmol/L individuals were classified as newly diagnosed diabetes, and individuals with intermediate hyperglycemia with FPG levels of 6.1 to 6.9 mmol/L or with 2-hour plasma glucose levels of 7.8 to 11.0 mmol/L as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), respectively. Individuals with FPG levels of Ͻ6.1 mmol/L were classified as normal fasting glucose (NFG), and with 2-hour PG levels of Ͻ7.8 mmol/L as normal glucose tolerance (NGT).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of the First Stroke Events</head><p>First (incident) stroke events consisted of acute stroke events in individuals without a history of stroke before the baseline survey. Incidence of stroke was coded according to the International Classification of Diseases (8th, 9th, and 10th revisions) with codes 430 to 431, 433 to 434, 436 and I60 to I61, I63 to I64 for nonfatal and fatal stroke, and further classified into subtypes of stroke coding 433, 434, and I63 for ischemic stroke and 430 to 431 and I60 to I61 for hemorrhagic stroke and cases that could not be specified into unspecified stroke. Individuals, who had emigrated, whose vital status could not be confirmed, or individuals with a prior history of CVD (including stroke) at the baseline survey were excluded from the data analysis.</p><p>The local Ethics Committees had approved each individual study plan, and the data analysis plan was approved by the Ethics Committee of the National Public Health Institute, Finland.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Methods</head><p>The data analysis was carried out using SPSS for Windows version 15.0. General linear model of the univariate analysis of variance was used to estimate the means according to FPG and 2-hour PG classes adjusting for age, center, and sex. Hazard ratios with 95% confidence intervals for stroke incidence were estimated for different glucose categories and also for a 1-SD increase in 2-hour PG (mmol/L) and FPG (mmol/L) criteria using Cox proportional hazards model. The FPG or 2-hour PG has been divided by their standard deviations to make them comparable. The analysis was adjusted for age, center, mean arterial pressure (MAP, as an alternative systolic blood pressure was also tested, and the results are shown in the text in the Result section), body mass index (BMI), total serum cholesterol, smoking status, and sex. MAP was defined as [(2ϫdiastolic)ϩsystolic]/3 and BMI was calculated by using weight in kilograms divided by the square of height in meters and smoking status was categorized as current smoker, ex-smoker, or nonsmoker. Chi-squared log-likelihood ratio test were used to evaluate whether the 2 glucose criteria differ in their prediction of the new events of stroke.</p><p>Considering the variations in follow-up length, events rates, and risk factor levels between studies, particularly among the old Finnish policemen study, a stratified Cox regression analysis with "study" as Strata was also fitted and the results are shown and compared with those from the model where "study" was considered as a covariate. A sensitivity analysis truncating the follow-up length at 15 years was performed to check to what extent the difference in follow-up length could affect the results.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The demographic data at baseline and the number of subjects in each cohort are shown in Table <ref type="table" target="#tab_0">1</ref>. Of the total 998 (5.4%) incident stroke events observed, 757 (4.1%) were ischemic, 196 (1.1%) were hemorrhagic, and 45 (0.2%) unspecified strokes (Table <ref type="table" target="#tab_0">1</ref>). The characteristics of subjects according to different glucose categories are shown in Table <ref type="table" target="#tab_1">2</ref>. Individuals with both diagnosed and undiagnosed diabetes were older and had higher BMI compared to individuals without diabetes (Table <ref type="table" target="#tab_1">2</ref>). Among 1254 screen detected diabetic individuals, 368 (29%) met only the FPG criterion, 536 (43%) only the 2-hour PG criterion, and 350 (28%) qualified for the both diagnostic criteria for diabetes.</p><p>Multivariate-adjusted hazard ratios corresponding to a 1-SD increase in both FPG and 2-hour PG significantly predicted the incidence of ischemic stroke and overall stroke, but not hemorrhagic stroke subtype (Table <ref type="table" target="#tab_2">3</ref>). The loglikelihood ratio test showed that inclusion of 2-hour PG to the model with FPG improved the prediction of ischemic stroke ( 2 ϭ4.72, Pϭ0.03) and all stroke subtypes ( 2 ϭ4.93, Pϭ0.03). In contrast, the inclusion of FPG to the model with 2-hour PG did not improve the prediction either of ischemic stroke ( 2 ϭ0.25, Pϭ0.62) or overall ( 2 ϭ0.79, Pϭ0.37) stroke incidence (Table <ref type="table" target="#tab_2">3</ref>). Similar results were obtained from stratified Cox-regression analyses, which gave hazard ratios of 1.11 (1.02 to 1.22; 95% CI) and 1.14 (1.05 to 1.24; 95% CI) for ischemic stroke corresponding to a 1-SD increase in FPG and 2-hour PG, respectively. The stratified Cox regression analysis also showed that addition of the 2-hour PG to the model with FPG improved the model prediction ( 2 ϭ4.97, Pϭ0.03), but adding the FPG to the model with Replacing the MAP with systolic blood pressure in the Cox regression analysis did not change the results substantially with hazard ratios of 1.11 (1.01 to 1.22; 95% CI) and 1.14 (1.05 to 1.23; 95% CI) for ischemic stroke corresponding to a 1SD increase in FPG and 2-hour PG. The analysis with systolic blood pressure consistently showed that 2-hour PG was a better predictor ( 2 ϭ4.30, Pϭ0.04) than FPG ( 2 ϭ0.25, Pϭ0.62) for ischemic stroke.</p><p>As compared with individuals with normal glucose levels, the hazard ratios for the ischemic stroke were higher for individuals with previously diagnosed diabetes and screendetected diabetes defined by either FPG or 2-hour PG criteria (Table <ref type="table" target="#tab_3">4</ref>). The elevated FPG as well as the 2-hour PG did not predict the hemorrhagic stroke. The results of the sensitivity analysis, for which the follow-up length was truncated at 15 years, were in accordance with the present findings.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The present study, based on 9 northern European cohorts with a median length of follow-up of 12.9 years, indicated that in individuals without previous diagnosis of diabetes the risk of ischemic stroke increased with increasing FPG and 2-hour PG levels, but 2-hour PG contributed to the risk more strongly than FPG. The risk of ischemic stroke was clearly increased in individuals with previously diagnosed or screendetected diabetes. There was, however, no relationship between the degree of hyperglycemia and the risk of hemorrhagic stroke. Some, <ref type="bibr" target="#b16">17</ref> but not all, <ref type="bibr" target="#b5">6</ref> studies have reported an increased risk of ischemic stroke in individuals with diagnosed diabetes. Increased risk of ischemic stroke has also been found in individuals with elevated serum fasting <ref type="bibr" target="#b11">12</ref> and nonfasting <ref type="bibr" target="#b4">5</ref> glucose levels and in individuals with diabetes defined by FPG 1 or 1-hour postload glucose levels. <ref type="bibr" target="#b1">2</ref> Atherosclerosis, assessed by carotid artery stenosis or by carotid intima-media thickness, has been shown to increase the incidence of ischemic stroke <ref type="bibr" target="#b7">8</ref> and to be more clearly associated with elevated postchallenge glucose levels than with fasting glucose levels. <ref type="bibr" target="#b10">11</ref> Studies comparing different degrees of hyperglycemia defined by FPG and 2-hour PG criteria and the incidence of stroke are, however, scarce. With a large sample size, the comparison between the 2 glucose criteria with the subtypes of stroke was investigated in the present study, and the elevated 2-hour PG appeared to be slightly stronger than FPG with regard to the prediction of the ischemic stroke in the whole study population.</p><p>The association between the incidence of hemorrhagic stroke and diabetes is controversial. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b12">13</ref> Studies have found an increased risk <ref type="bibr" target="#b12">13</ref> of hemorrhagic stroke in individuals with diabetes diagnosed by fasting glucose levels, no association in individuals with overt diabetes <ref type="bibr" target="#b17">18</ref> or with diabetes defined by 1-hour postload glucose measurement, <ref type="bibr" target="#b2">3</ref> or a decreased risk <ref type="bibr" target="#b3">4</ref> in individuals with overt diabetes. The etiology and pathophysiology of the ischemic and hemorrhagic stroke are different, <ref type="bibr" target="#b6">7</ref> which might also indicate different risk factors for  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hyvarinen et al Hyperglycemia and Stroke Incidence</head><p>the 2 stroke subtypes. In the present study, no relationship of hemorrhagic stroke with the elevated FPG or 2-hour PG was found.</p><p>The strength of the present study includes the long length of follow-up and the collaborative data analysis, which increased statistical power and made it possible to run data analyses in details. The national death and hospital discharge registers in Finland <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref> and Sweden <ref type="bibr" target="#b20">21</ref> provide complete follow-up information for outcomes. Additionally, the accuracy of the stroke diagnoses in the Hospital Discharge Register and Causes of Death Register when comparing the stroke events to the data provided by the population-based stroke registers in Finland <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref> and Sweden 21 has been found to be fairly good. There are, however, variations in study design, laboratory assays, the follow-up length, and the event rates in between the studies. This may cause the problem when classifying people into categories. In this study, however, no other measures rather than glucose were studied. To overcome this limitation, glucose variables have been analyzed in both the categorical form and the linear form after standardized to a 1-SD increase. In addition, we have fitted the "study cohort" as a covariate in the data analysis, performed data analysis based on each single study instead of pooling all studies together and run a multivariate adjusted stratified Cox-regression analysis as well. All the results are shown in the manuscript; the main results and conclusion remain, however, unchanged regardless of what data analysis strategies were applied. To replace the MAP with systolic blood pressure in the data analysis did not alter the results either.</p><p>Regardless of the relatively large sample size, the low number of hemorrhagic stroke has impaired the precise estimates of the impact of hyperglycemia on hemorrhagic stroke. Also, the follow-up length for many of the cohorts is still short with the low stroke events accumulated, particularly when the strict criteria for acute stroke was applied. This made it impossible to analyze the data separately for men and women; therefore, whether the effect is the same for men as for women is still not known and needs to be further explored in the future.</p><p>In summary, this study showed that in individuals without previous diagnosis of diabetes the risk of ischemic stroke increased with increasing FPG and 2-hour PG levels, 2-hour PG contributing to the risk more strongly than FPG. Diabetes, both previously diagnosed and screen-detected, was associated with clearly increased risk of ischemic stroke. No relationship between hyperglycemia and the risk of hemorrhagic stroke was found. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Demographic and Follow-Up Information of the Study Populations</head><label>1</label><figDesc></figDesc><table><row><cell>Median (Range), Years</cell><cell>Stroke, n (%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 . Characteristics of Subjects at Baseline and Stroke Events Accumulated According to Fasting and 2-Hour Glucose Criteria</head><label>2</label><figDesc></figDesc><table><row><cell></cell><cell cols="3">Fasting Plasma Glucose (mmol/L)</cell><cell cols="3">2-Hour Plasma Glucose (mmol/L)</cell><cell></cell></row><row><cell></cell><cell>Ͻ6.1</cell><cell>6.1-6.9</cell><cell>Ն7.0</cell><cell>Ͻ7.8</cell><cell>7.8 -11.0</cell><cell>Ն11.1</cell><cell>Known DM</cell></row><row><cell>n (%)</cell><cell>13601 (74.1)</cell><cell>3168 (17.3)</cell><cell>718 (3.9)</cell><cell>12573 (68.5)</cell><cell>4028 (21.9)</cell><cell>886 (4.8)</cell><cell>873 (4.8)</cell></row><row><cell>Age</cell><cell>54.6 (0.1)</cell><cell>55.8 (0.2)</cell><cell>58.3 (0.3)</cell><cell>53.6 (0.1)</cell><cell>58.0 (0.1)</cell><cell>59.8 (0.2)</cell><cell>60.4 (0.3)</cell></row><row><cell>Body mass index, kg/m 2</cell><cell>26.3 (0.0)</cell><cell>27.6 (0.1)</cell><cell>29.8 (0.2)</cell><cell>26.4 (0.0)</cell><cell>27.0 (0.1)</cell><cell>29.1 (0.2)</cell><cell>29.3 (0.2)</cell></row><row><cell>Cholesterol, mmol/L</cell><cell>6.04 (0.01)</cell><cell>6.10 (0.02)</cell><cell>6.17 (0.04)</cell><cell>6.03 (0.01)</cell><cell>6.12 (0.02)</cell><cell>6.12 (0.04)</cell><cell>5.81 (0.04)</cell></row><row><cell>Systolic blood pressure, mm Hg</cell><cell>137 (0.2)</cell><cell>141 (0.3)</cell><cell>146 (0.7)</cell><cell>138 (0.2)</cell><cell>139 (0.3)</cell><cell>147 (0.7)</cell><cell>147 (0.7)</cell></row><row><cell>Diastolic blood pressure, mm Hg</cell><cell>83 (0.1)</cell><cell>84 (0.2)</cell><cell>87 (0.4)</cell><cell>83 (0.1)</cell><cell>84 (0.2)</cell><cell>86 (0.4)</cell><cell>83 (0.4)</cell></row><row><cell>Smoking, n (%)</cell><cell>3206 (23.6)</cell><cell>913 (28.8)</cell><cell>195 (27.2)</cell><cell>3245 (25.8)</cell><cell>887 (22.0)</cell><cell>182 (20.5)</cell><cell>181 (20.7)</cell></row><row><cell>Stroke, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>All-causes</cell><cell>654 (4.8)</cell><cell>198 (6.3)</cell><cell>56 (7.8)</cell><cell>626 (5.0)</cell><cell>215 (5.3)</cell><cell>67 (7.6)</cell><cell>90 (10.3)</cell></row><row><cell>Ischemic stroke</cell><cell>494 (3.6)</cell><cell>150 (4.7)</cell><cell>46 (6.4)</cell><cell>475 (3.8)</cell><cell>163 (4.0)</cell><cell>52 (5.9)</cell><cell>67 (7.7)</cell></row><row><cell>Hemorrhagic stroke</cell><cell>137 (1.0)</cell><cell>38 (1.2)</cell><cell>5 (0.7)</cell><cell>127 (1.0)</cell><cell>42 (1.0)</cell><cell>11 (1.2)</cell><cell>16 (1.8)</cell></row><row><cell>Unspecified stroke</cell><cell>23 (0.2)</cell><cell>10 (0.3)</cell><cell>5 (0.7)</cell><cell>24 (0.2)</cell><cell>10 (0.2)</cell><cell>4 (0.5)</cell><cell>7 (0.8)</cell></row><row><cell cols="4">Data are given as means (SE) adjusted for age, study, and sex, or as n (%) as noted.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 . Hazard Ratios (95% Confidence Intervals) for the Incidence of Overall and Subtypes of Stroke Corresponding to a 1-SD Increase in Fasting (FPG) and 2-Hour Plasma Glucose (2-Hour PG) Levels (mmol/L)</head><label>3</label><figDesc>The 2 indicates the changes in the model prediction when the variable indicated was removed from the model with both FPG and 2-hour PG simultaneously. Subjects with previously diagnosed diabetes are excluded. 1 SD is 1.2 for FPG and 2.7 for 2-hour PG. Adjusted for age, study, BMI, total cholesterol, smoking, MAP, and sex.</figDesc><table><row><cell></cell><cell></cell><cell>Stroke Incidence</cell><cell></cell></row><row><cell></cell><cell>Ischemic</cell><cell>Hemorrhagic</cell><cell>All-Causes</cell></row><row><cell>No. of events</cell><cell>69</cell><cell>180</cell><cell>908</cell></row><row><cell>FPG</cell><cell>1.12 (1.02-1.22)</cell><cell>1.07 (0.88-1.30)</cell><cell>1.12 (1.04-1.21)</cell></row><row><cell>2-hour PG</cell><cell>1.14 (1.05-1.24)</cell><cell>1.06 (0.90-1.27)</cell><cell>1.14 (1.06-1.22)</cell></row><row><cell>2 for FPG, 1</cell><cell>0.25 (0.62)</cell><cell>0.17 (0.68)</cell><cell>0.79 (0.37)</cell></row><row><cell>df (p)*</cell><cell></cell><cell></cell><cell></cell></row><row><cell>2 for 2-hour</cell><cell>4.72 (0.03)</cell><cell>0.09 (0.76)</cell><cell>4.93 (0.03)</cell></row><row><cell>PG, 1 df (p)*</cell><cell></cell><cell></cell><cell></cell></row></table><note>*</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 . Hazard Ratios (95% Confidence Intervals) for Stroke Incidence According to Fasting Plasma Glucose (mmol/L) and 2-Hour Plasma Glucose (mmol/L) Categories</head><label>4</label><figDesc></figDesc><table><row><cell></cell><cell></cell><cell cols="2">Fasting Plasma Glucose Category</cell><cell></cell><cell></cell><cell cols="2">2-Hour Plasma Glucose Category</cell><cell></cell></row><row><cell>Stroke Type</cell><cell>Ͻ6.1</cell><cell>6.1 to 6.9</cell><cell>Ն7.0</cell><cell>Known DM</cell><cell>Ͻ7.8</cell><cell>7.8 to 11.0</cell><cell>Ն11.1</cell><cell>Known DM</cell></row><row><cell>Ischemic</cell><cell>1</cell><cell>1.18 (0.97-1.43)</cell><cell>1.48 (1.08 -2.02)</cell><cell>2.20 (1.48 -3.29)</cell><cell>1</cell><cell>1.14 (0.93-1.38)</cell><cell>1.60 (1.18 -2.16)</cell><cell>2.26 (1.51-3.38)</cell></row><row><cell>Hemorrhagic</cell><cell>1</cell><cell>1.14 (0.78-1.67)</cell><cell>0.61 (0.25-1.52)</cell><cell>2.23 (0.96-5.18)</cell><cell>1</cell><cell>1.05 (0.72-1.55)</cell><cell>1.29 (0.67-2.45)</cell><cell>2.32 (0.99-5.42)</cell></row><row><cell>All-causes</cell><cell>1</cell><cell>1.18 (1.00-1.40)</cell><cell>1.36 (1.02-1.80)</cell><cell>2.26 (1.59-3.22)</cell><cell>1</cell><cell>1.14 (0.96-1.35)</cell><cell>1.57 (1.20-2.04)</cell><cell>2.33 (1.64-3.33)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Downloaded from http://ahajournals.org by on June 29, 2021</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">May 2009 Downloaded from http://ahajournals.org by on June 29, 2021</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix</head><p>The DECODE Study (Diabetes Epidemiology: Collaborative analysis Of Diagnostic Criteria in Europe) was started in 1997 on the initiative of the European Diabetes Epidemiology Group.</p><p>Studies and investigators in this collaborative study are:</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Finland East-West</head><p>A. Nissinen, 1 J. Pekkanen, 1 J. Tuomilehto. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Helsinki Policemen Study</head><p>M. Pyo ¨ra ¨la ¨, K. Pyo ¨ra ¨la ¨. Department of Medicine, University of Kuopio.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Vantaa Study</head><p>R. Tilvis, 1 S. Sairanen, 1 J. Tuomilehto. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secretariat</head><p>Q. Qiao, 1 K. Borch-Johnsen, 2 J. Tuomilehto. <ref type="bibr" target="#b0">1</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data Analysis</head><p>M. Hyva ¨rinen, 1 Q. Qiao, 1,2 L. Zhang, 1,2 W. Gao. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sources of Funding</head><p>This analysis has been carried out with the help of grants from Finnish Academy (118492).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosures</head><p>None.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Prospective association of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Folsom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Heiss</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1999">1999</date>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1077" to="1083" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Factors related to stroke incidence in Hawaiian Japanese men: The Honolulu heart study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Popper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Rhoads</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="14" to="21" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Burchfiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Curb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Abbott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="951" to="957" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">European BIOMED of Stroke Care Group. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project</title>
		<author>
			<persName><forename type="first">S-E</forename><surname>Megherbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Milan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Minier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Osseby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Carlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Inzitari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Giroud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="688" to="694" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Risk-factor profile for the incidence of subarachnoid and intracerebral hemorrhage, cerebral infarction, and unspecified stroke during 21 years&apos; follow-up in men</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Lund Haheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Holme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hjermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tonstad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Public Health</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="589" to="597" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mortality and risk factors for stroke and its subtypes in a cohort study in Japan</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tokui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kubo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shirane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mizoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ogimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prev Med</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="526" to="530" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Pathophysiology and classification of stroke</title>
		<author>
			<persName><forename type="first">C</forename><surname>Collins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nurs Stand</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="35" to="39" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Hak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Koudstaal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bots</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Grobbee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hofman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Witteman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Breteler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="2367" to="2372" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Role of Insulin Resistance and Hyperglycemia in the Development of Atherosclerosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bansilal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Farkouh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fuster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="6B" to="14B" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Temelkova-Kurktschiev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Koehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Leonhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schaper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Henkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Siegert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hanefeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="333" to="338" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Post-challenge hyperglycaemia relates more strongly than fasting hyperglycemia with carotid intima-media thickness: the RIAD Study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hanefeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Koehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Henkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fuecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schaper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Temelkova-Kurktschiev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabet Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="835" to="840" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Different risk factor profiles between subtypes of ischemic stroke. A case-control study in Korean men</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ebrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sunwoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Yun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="605" to="612" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Risk factors for primary intracerebral hemorrhage</title>
		<author>
			<persName><forename type="first">E</forename><surname>Zia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pessah-Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Norrving</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Janzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Berglund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Engstrom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cerebrovasc Dis</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="18" to="25" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Schrier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Estacio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Mehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Hiatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Clin Pract Nephrol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="428" to="438" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Risk factors for intracerebral hemorrhage in the general population: a systematic review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ariesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Claus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Rinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Algra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="2060" to="2065" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">World Health Organization and International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia</title>
		<imprint>
			<date type="published" when="2006">2006</date>
			<publisher>WHO Document Production Services</publisher>
			<biblScope unit="page" from="13" to="27" />
			<pubPlace>Geneva, Switzerland</pubPlace>
		</imprint>
	</monogr>
	<note>Report of a WHO/IDF consultation</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Asia Pacific Cohort Studies Collaboration. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region</title>
		<author>
			<persName><forename type="first">M</forename><surname>Woodward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Barzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ueshima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macmahon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="360" to="366" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Risk factors for primary intracerebral hemorrhage in patients in Izumo City</title>
		<author>
			<persName><forename type="first">T</forename><surname>Inagawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Japan. Neurosurg Rev</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="225" to="234" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tolonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Salomaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Torppa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sivenius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">¨p</forename><surname>Immonen-Ra ¨iha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lehtonen</surname></persName>
		</author>
		<author>
			<persName><surname>For</surname></persName>
		</author>
		<author>
			<persName><surname>Register</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiovasc Prev Rehabil</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="380" to="385" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">FINMONICA Stroke Register Study group. The feasibility of combining data from routine hospital discharge and causesof-death registers for epidemiological studies on stroke</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ma ¨ho ¨nen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Salomaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Keskima ¨ki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Moltchanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Torppa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Molarius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tuomilehto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sarti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="815" to="817" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry</title>
		<author>
			<persName><forename type="first">B</forename><surname>Stegmayr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Asplund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroepidemiology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="204" to="213" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
